1. The MIN6 cell line derived from in vivo immortalized insulin-secreting pancreatic beta cells was used to study the insulin-releasing capacity and the cellular mode of action of S-22068, a newly synthesized imidazoline compound known for its antidiabetic effect in vivo. 2. S-22068, was able to release insulin from MIN6 cells in a dose-dependent manner with a half-maximal stimulation at 100 micronM. Its efficacy (8 fold over the basal value), which did not differ whatever the glucose concent...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound.
If you are the owner of this record, you can report an update to it here: Report update to this record